PNPLA3 and hepatocellular carcinoma: Two meta-analyses have confirmed these findings showing that cirrhotic carriers of the PNPLA3 variant protein had an increased risk of HCC (OR: 1.40, 95%CI: 1.12–1.75) [103] and that this higher HCC risk persisted even after adjusting for age, sex, and BMI [104].